English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2004]
News [3333]
Articles [144]
Editorials [3]
Conferences [125]
elearning [18]
Team discovers how to target ‘undruggable’ protein that fuels aggressive leukaemia
Team discovers how to target ‘undruggable’ protein that fuels aggressive leukaemia
ASH 2025: Tec-Dara combination offers substantial improvement over standard second-line therapies for relapsed or refractory multiple myeloma
ASH 2025: Tec-Dara combination offers substantial improvement over standard second-line therapies for relapsed or...
ASH 2025: Pirtobrutinib outperforms bendamustine plus rituximab for previously untreated CLL/SLL
ASH 2025: Pirtobrutinib outperforms bendamustine plus rituximab for previously untreated CLL/SLL
ASH 2025: Measurable residual disease shows strong potential as an early indicator of survival in acute myeloid leukaemia
ASH 2025: Measurable residual disease shows strong potential as an early indicator of survival in acute myeloid...
ASH 2025: Continuous and fixed-duration treatments result in similar outcomes for CLL
ASH 2025: Continuous and fixed-duration treatments result in similar outcomes for CLL
ASH 2025: Chemo and radiation are comparable as pre-transplant conditioning for B-acute lymphoblastic leukaemia with no measurable residual disease
ASH 2025: Chemo and radiation are comparable as pre-transplant conditioning for B-acute lymphoblastic leukaemia...
A routine blood test could help predict who benefits most from CAR T-cell therapy
A routine blood test could help predict who benefits most from CAR T-cell therapy
ASH 2025: Milder chemo works for rare, aggressive lymphoma
ASH 2025: Milder chemo works for rare, aggressive lymphoma
Study finds childhood leukaemia aggressiveness depends on timing of genetic mutation
Study finds childhood leukaemia aggressiveness depends on timing of genetic mutation
Prognostic tool could help clinicians identify high-risk cancer patients
Prognostic tool could help clinicians identify high-risk cancer patients
<12345…334>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top